Modification by two genes of associations between general somatic health and incident depressive syndrome in older people

Psychosomatic Medicine

Volumn 71, Issue 3, 2009, Pages 286-291

  Kim, Jae Min ^a   Stewart, Robert ^b   Kim, Sung Wan ^a   Yang, Su Jin ^a   Shin, Il Seon ^a   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic disease; Depression; Gene environment interaction.; Genes; Methylenetetrahydrofolate reductase; Serotonin transporter

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); SEROTONIN TRANSPORTER; 5,11 METHENYLTETRAHYDROHOMOFOLIC ACID; 5,11-METHENYLTETRAHYDROHOMOFOLATE; DRUG DERIVATIVE; FOLIC ACID; PRIMER DNA; SLC6A4 PROTEIN, HUMAN;

AGED; ALLELE; ARTICLE; ASIAN; DEPRESSION; DISEASE ASSOCIATION; DNA MODIFICATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GERIATRIC MENTAL STATE; GERIATRIC PATIENT; GERIATRICS; HEALTH; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MORBIDITY; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SCORING SYSTEM; SEROTONIN TRANSPORTER GENE; SOMATIC MUTATION; CHRONIC DISEASE; GENETICS; HEALTH STATUS; HOSPITALIZATION; POLYMERASE CHAIN REACTION; SOMATOFORM DISORDER; SYNDROME;

AGED; CHRONIC DISEASE; DEPRESSIVE DISORDER; DNA PRIMERS; FEMALE; FOLIC ACID; GENOTYPE; HEALTH STATUS; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; SOMATOFORM DISORDERS; SYNDROME;

EID: 68549120886     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181990fff     Document Type: Article

References (42)

1. Wells KB, Golding JM, Burnham MA. Psychiatric disorder in a sample of the general population with and without medical disorder. Am J Psychiatry 1988;145:976-81.
2. Patten S. Long-term medical conditions and major depression in a Canadian population study at wave 1 and 2. J Affect Disord 2001;63:35-41.
3. Prince MJ, Harwood RH, Blizard RA, Thomas A, Mann AH. Impairment, disability and handicap as risk factors for depression in old age. The Gospel Oak Project V. Psychol Med 1997;27:311-21.
4. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-26.
5. Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U, Riederer P, Lesch KP. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect 1995;102:247-54.
6. Anguelova M, Benkelfat C, Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter. I. Affective disorders. Mol Psychiatry 2003;8: 574-91.
7. Caspi A, Sugden K, Moffitt TE, Talyor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braitwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-9.
8. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 2007;62: 423-8.
9. Nakatani D, Sato H, Sakata Y, Shiotani I, Kinjo K, Mizuno H, Shimizu M, Ito H, Koretsune Y, Hirayama A, Hori M. Osaka Acute Coronary Insufficiency Study Group. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005;150:652-8.
10. Otte C, McCaffery J, Ali S, Whooley MA. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the heart and soul study. Am J Psychiatry 2007;164:1379-84.
11. Ramasubbu R, Tobias R, Buchan AM, Bech-Hansen NT. Serotonin transporter gene promoter region polymorphism associated with post-stroke major depression. J Neuropsychiatry Clin Neurosci 2006;18:96-9.
12. Mössner R, Henneberg A, Schmitt A, Syagailo YV, Grässle M, Hennig T, Simantov R, Gerlach M, Riederer P, Lesch KP. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 2001;6:350-2.
13. Lenze EJ, Munin MC, Ferrell RE, Pollock BG, Skidmore E, Lotrich F, Rogers JC, Quear T, Houck P, Reynolds CF 3rd. Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depression in elderly persons after hip fracture. Am J Geriatr Psychiatry 2005;13:428-32.
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
15. López-León S, Janssens AC, González-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, van Duijn CM. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008;13:772-85.
16. 12, homocysteine levels in late-life depression. Br J Psychiatry 2008;192:268-74.
17. Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, Tverdal A, Tell GS, Nygård O, Vollset SE. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006;136(suppl 6):1731-40.
18. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M; 10/66 Dementia Research Group. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003;361:909-17.
19. Kim JM, Stewart R, Shin IS, Jung JS, Yoon JS. Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population. Neurobiol Aging 2004;25:295-301.
20. Kim JM, Stewart R, Shin IS, Yoon JS. Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatry 2004;185: 102-7.
21. Kim JM, Stewart R, Kim SW, Shin IS, Yang SJ, Yoon JS. Vascular disease/risk as prospective risk factors for late-life depression. Br J Psychiatry 2006;189:26-30.
22. Copeland JRM, Dewey ME, Griffiths-Jones HM. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 1986;16:89-99.
23. Kim JM, Stewart R, Prince M, Shin IS, Yoon JS. Diagnosing dementia in a developing nation: an evaluation of the GMS-AGECAT algorithm in an older Korean population. Int J Geriatr Psychiatry 2003;18:331-6.
24. Lindesay J. The Guy's/Age Concern Survey: physical health and psychiatric disorder in an urban elderly community. Int J Geriatr Psychiatry 1990;5:171-8.
25. Prince MJ, Harwood RH, Thomas A, Mann AH. A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak Project VII. Psychol Med 1998;28:337-50.
26. Edenberg HJ, Reynolds J. Improved method for detecting the long and short promoter alleles of the serotonin transporter gene HTT (SLC6A4) Psychiatr Genet 1998;8:193-5.
27. Kim JM, Stewart R, Glozier N, Prince M, Kim SW, Yang SJ, Shin IS, Yoon JS. Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int J Geriatr Psychiatry 2005;20:160-7.
28. Hoffman C, Rice D, Sung HY. Persons with chronic conditions. Their prevalence and costs. JAMA 1996;276:1473-9.
29. Taylor WD, Steffens DC, Payne ME, MacFall JR, Marchuk DA, Svenson IK, Krishnan KR. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. Arch Gen Psychiatry 2005;62:537-44.
30. Hickie IB, Naismith SL, Ward PB, Scott EM, Mitchell PB, Schofield PR, Scimone A, Wilhelm K, Parker G. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord 2007;98:137-42.
31. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression. Arch Gen Psychiatry 2005;62:529-35.
32. Ha TM, Cho DM, Park SW, Joo MJ, Lee BJ, Kong BG, Kim JM, Yoon JS, Kim YH. Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients. Dement Geriatr Cogn Disord 2005;20:31-4.
33. Visvikis-Siest S, Marteau JB. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 2006;17:139-51.
34. Cronin S, Furie KL, Kelly PJ. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 2005;36:1581-7.
35. Yoo JH, Choi GD, Kang SS. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 2000;20:1921-5.
36. Lewis SJ, Lawlor DA, Davey Smith G, Araya R, Timpson N, Day IN, Ebrahim S. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry 2006;11:352-60.
37. Almeida OP, Flicker L, Lautenschlager NT, Leedman P, Vasikaran S, van Bockxmeer FM. Contribution of the MTHFR gene to the causal pathway for depression, anxiety and cognitive impairment in later life. Neurobiol Aging 2005;26:251-7.
38. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SM. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:195-201.
39. Alpert M, Silva RR, Pouget ER. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol 2003;23:309-13.
40. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS. BDNF genotype potentially modifying the association between incident stroke and depression. Neurobiol Aging 2008;29:789-92.
41. Peabody JW, Robalino DA, Kim JH. An evaluation of universal health insurance in the elderly: burden of disease, utilization, and costs in the Republic of Korea. J Aging Health 2002;14:286-309.
42. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-8.